| Name | CasNo | Structure | Remarks | Scale |
| Diethyl chloromalonate,氯代丙二酸二乙酯 | 14064-10-9 |  |
intermediate | 94%，无色透明液体 |
| DL-alpha-Amino-epsilon-caprolactam Hydrochloride,DL-α-氨基-ε-己内酰胺盐酸盐 | 29426-64-0 |  |
intermediate | 类白色粉末状固体 ,HPLC:99% |
| Pyrimidine,2,4,6-tris(1,1-dimethylethyl)- 2,4,6-三叔丁基嘧啶 | 67490-21-5 |  |
intermediate | 白色固体,99% |
| 2,2-dimethyl-4,7-dihydro-1,3-dioxepine,4,7-二氢-2,2-二甲基-1,3-二氧杂环庚-5-稀 | 1003-83-4 |  |
intermediate | 99%,无色透明液体 |
| 4,4-Dimethyl-3,5,8-trioxabic-yclo[5,1,0]Octane，4,4-二甲基-3,5,8-三氧杂双环[5,1,0]辛烷 | 57280-22-5 |  |
intermediate | 99%,无色透明液体 |
| Glycine, N-(2-nitrobenzoyl)- , N-(2-硝基苯甲酰基) 甘氨酸 | 10167-23-4 |  |
intermediate | 98%,白色固体 |
| Glycine, N-(2-aminobenzoyl)-, phenylmethyl ester 2-氨基苯甲酰甘氨酸苄酯 | 150374-97-3 |  |
Intermediate of sivelestat sodium | 白色固体 |
| L-2-Aminobutanamide hydrochloride L-2-氨基丁酰胺盐酸盐 | 7682-20-4 |  |
Intermediate of Levetiracetam | 白色固体 |
| Levetiracetam 左乙拉西坦 | 102767-28-2 |  |
API | 白色固体，USP32增补版 |
| L-Glutamic acid 5-benzyl ester L-谷氨酸-5-苄酯 | 1676-73-9 |  |
intermediate | 98%,白色固体 |
| (R)-(-)-2-Phenylpropionic acid R-2-苯基丙酸 | 7782-26-5 |  |
intermediate | 98%,ee:98% (HPLC) |
| (S)-(+)-2-Phenylpropionic Acid S-2-苯基丙酸 | 7782-24-3 |  |
intermediate | ee:98% (HPLC) |
| 1H-Benzimidazole-1-butanoicacid, 2,3-dihydro-2-oxo- 2，3-二氢-2-氧，1H-苯并咪唑-1-丁酸 | 3273-68-5 |  |
intermediate | 白色固体 |
| Acetamide, N-(3-acetyl-2-hydroxyphenyl)- N-（3-乙酰基-2-羟基-苯基）-乙酰胺 | 103205-33-0 |  |
intermediate | 白色固体 |
| 4-(4-Phenylbutoxy)benzoic acid 对苯丁氧基苯甲酸 | 30131-16-9 |  |
Intermediate of Pranlukast | 白色固体，99% 111 |
| Name | CasNo | Structure | Remarks | Scale |
| 4H-1-Benzopyran-4-one, 8-amino-2- (2H-tetrazol-5-yl)-, hydrochloride 8-氨基-2-（1H-5-四唑）-4-苯并吡喃酮 | 110683-23-3 |  |
Intermediate of Pranlukast | 黄色粉末固体 HPLC：98% |
| 3-[4-(4-苯基丁氧基)苯甲酰基氨基]-2-羟基苯乙酮，3''-acetyl-2''-hydroxy-4-(4-phenylbytoxy)benzanlide | 136450-06-1 |  |
Intermediate of Pranlukast | 白色固体 |
| 2-氯-5-氨基苯酚，2-Chloro-5-aminophenol | 6358-6-1 |  |
intermediate | 99% |
| Benzenamine, 4-chloro-3-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]- 3-氯-2-（2-氯-5-氨基-苯氧基）-5-三氟甲氧基吡啶 | 87170-48-7 |  |
Intermediate of Fluazuron | 外观：棕色粉末，HPLC:97.5% |
| 2-Chloro-3-bromomethyl thiophene 2-氯-3-溴甲基噻吩 | 40032-81-3 |  |
Intermediate of Vagistat | 97%,浅黄色 透明液体 |
| 2,4-Dichloro-alpha-(chloromethyl)benzyl alcohol 2,4-二氯-α-氯甲基苯甲醇 | 13692-14-3 |  |
Intermediate of Vagistat | 白色晶体 |
| 1-(2,3-Dichlorophenyl)piperazine Hydrochloride 1-(2,3-二氯苯基)哌嗪盐酸盐 | 119532-26-2 | 哌嗪盐酸盐.JPG) |
Intermediate of Aripiprazole | 外观:类白色或白色粉末 |
| 3,4-Dihydro-7-hydroxy-2(1H)-quinolinone 3,4-二氢-7-羟基-2(1H)-喹啉酮 | 22246-18-0 | -喹啉酮.JPG) |
Intermediate of Aripiprazole | 外观:淡黄色粉末，HPLC:98% |
| (S)-2-(1,3-Dioxo-1,3-dihydroisoindol-2-yl)pentanedioic acid 5-benzylester S)-2-(1,3-二氧代-1,3-二氢异吲哚-2-基)戊二酸-5-苄酯 | 88784-33-2 |  |
Intermediate of Cilazapril | 外观：白色固体 e.e:98.5%(HPLC) |
| 72120-54-8 | 六氢哒嗪-3-甲酸.JPG) |
Intermediate of sivelestat sodium | 98%,白色固体 | |
|
p-Pivaloyloxybenzenes ulfonic acid Sodium 对-（新戊酰氧基）苯磺酸钠 |
188114-91-2 |  |
Intermediate of sivelestat sodium | 98%,白色固体 |
| 4-(chlorosulfonyl)phenyl ester对新戊酰氧基苯磺酰氯 | 150374-99-5 |  |
intermediate | 99% |
| Glycine, N-(2-aminobenzoyl)- N-(2-氨基苯甲酰基) 甘氨酸 | 526-21-6 | Intermediate of sivelestat sodium | 98%,白色固体 | |
| Piperidine, 1-(phenylsulfinyl)- 1-(苯基亚硫酰基)哌啶 | 4972-31-0 |  |
intermediate | 白色固体 |
| a-D-Mannopyranoside, phenyl 2,3-bis-O-(phenylmethyl)-4,6-O-[(R)-phenylmethylene]-1-thio- 2,3-双-O-(苯基甲基)-4,6-O-[(R)-苯基亚甲基]-1-硫代- a-D--吡喃甘露糖苷苯酯 | 159407-17-7 |  |
Intermediate | 95%(NMR)，白色固体 1111 |
| Name | CasNo | Structure | Remarks | Scale |
| Emtiricitabine，恩曲他滨 | 143491-57-0 |  |
API | 白色固体 |
| (2R,5S)-5-(4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-Oxathiolane-2-carboxylic acid, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester；FCME，(2R,5S)-5-(4-氨基-5-氟-2-氧代-1(2H)-嘧啶基)-1,3-噁噻烷-2-羧酸 (1R,2S,5R)-5-甲基-2-(1-甲基乙基)环己酯 | 764659-72-5 |  |
intermediate of Emtiricitabine | 99% |
| Lamivudine，拉米夫定 | 134678-17-4 |  |
api | 99% |
| Benzenepropanamide, N-[(1S)-2-methyl-1-(1-pyrrolidinylcarbonyl)propyl]-；AS-1 | 566914-00-9 |  |
intermedite | 99% |
| Octocrilene 奥克立林 | 6197-30-4 |  |
API | 无色或浅黄色液体,99% |
| 1,4-Hexanedione, 1-(4-fluorophenyl)-5-methyl-2-phenyl- 1-（4-氟苯基）-5-甲基-2-苯基-1，4-己二酮 | 111011-79-1 |  |
Intermediate of Atorvastatin | 95%，黄色透明液体 |
| 3-Amino-but-2-enoic acid 2-(benzyl-phenyl-amino)-ethyl ester 2-丁烯酸-3-氨基-2-[苯基（苯甲基）氨基]乙酯 | 111011-79-1 |  |
Intermediate of Efonidipine | 外观:白色固体，99% |
| 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride 3-(三氟甲基)-5,6,7,8-四氢-[1,2,4]三唑并[4,3-A]吡嗪盐酸盐 | 486460-21-3 |  |
Intermediate of Sitagliptin phosphate | 外观：白色结晶性粉末，99% |
| 1-Methyl-L-4,5-dihydroorotic acid 1-甲基-l-4，5-二氢乳清酸 | 103365-69-1 |  |
Intermediate of Taltirelin | 98%,白色固体 |
| 2,5-Diamino-4,6-dihydroxypyrimidine hydrochloride 2，5-二氨基-4，6-二羟基嘧啶盐酸盐 | 56830-58-1 |  |
Intermediate of Abacavir | 外观:浅黄色固体，98% |
| Piperazine, 1,4-diacetyl- 1，4-二乙酰基哌嗪 | 18940-57-3 |  |
intermediate | 99%，白色固体 |
| Trimethyl pyruvic acid 三甲基丙酮酸 | 815-17-8 |  |
intermediate | 外观:无色至浅黄色液体，98% |
| 4-(3-Chloro-4-fluorophenyl)-4-oxobutyric acid 4-（3-氯-4-氟苯基）-4-氧代丁酸 | 62903-16-6 |  |
intermediate | 98%,淡黄色固体 |
| Benzoic acid, 4-hydroxy-, 4-butoxyphenyl ester 对羟基苯甲酸对丁氧基苯酯 | 70568-44-4 |  |
intermediate | 98%,白色固体 |
| 6,6-Dimethyl-3-oxabicyclo[3.1.0]hexane-2,4-dione （Caronic anhydride） 6,6-二甲基-3-氧杂双环[3,2,1]己烷-2,4-二酮（卡龙酸酐） | 67911-21-1 |  |
intermediate | 99%，白色结晶固体 |
| Name | CasNo | Structure | Remarks | Scale |
| Dimethyl dimethylmalonate 2,2-二甲基丙二酸二甲酯 | 6065-54-9 |  |
intermediate | 99%，无色透明液体 |
| Pyrazolidine, hydrochloride (1:2) 吡唑啉盐酸盐 | 89990-54-5 |  |
intermediate | 99%，白色固体 |
| 1H,5H-Pyrazolo[1,2-a]pyrazol-1-one, 3-amino-6,7-dihydro-, hydrochloride (1:1) 1H,5H-吡唑并[1,2-a]吡唑-1-酮, 3-氨基-6,7-二氢-,盐酸盐 | 358360-19-7 |  |
intermediate | 99%,白色固体 |
| Bromoaceticacid sodium salt 溴乙酸钠 | 1068-52-6 |  |
intermediate | 白色固体 |
| 3-Acetylamino-propionic acid，N-乙酰基-belta-丙氨酸 | 3025-95-4 |  |
intermediate | 99% |
| D-(+)-Mannose，甘露糖 | 3458-28-4 |  |
intermediate | 98%,白色固体 |
| beta-D-Glucose pentaacetate，1,2,3,4,6-beta-D-葡萄糖五乙酸酯 | 604-69-3 |  |
intermediate | 98%,白色固体 |
| Methyl-2-deoxy-alpha-D-ribofuranoside，甲基-2-脱氧-alpha-D-呋喃核糖苷 | 51255-17-5 |  |
intermediate | 99% |
| 2,3,4,6-TETRA-O-ACETYL-BETA-D-GLUCOPYRANOSE, | 4291-69-4 |  |
intermediate | 98% |
| 2,3,4,6-TETRA-O-ACETYL-BETA-D-GLUCOPYRANOSE | 3947-62-4 |  |
intermediate | 98% |
| METHYL BETA-D-GLUCOPYRANOSIDE，甲基 Β-D-吡喃葡萄糖苷 | 709-50-2 |  |
intermediate | 98% |
| Methyl 2,3-Dideoxy-3-fluoro-5-O-(4-phenylbenzoyl)-，甲基2,3 - 二脱氧-3 - 氟-5-O -（4 - 苯基苯甲酰基） - α - D-赤型 - 呋喃戊糖苷 | 129468-51-5 |  |
intermediate | 98% |
| β-D-Galactopyranoside, methyl 2,3,4,6-tetrakis-O-(phenylmethyl)- | 3879-79-6 |  |
intermediate | 98% |
| β-D-Glucopyranose, 2,3,4,6-tetrakis-O-(phenylmethyl)-, 1-(2,2,2-trichloroethanimidate) | 90357-89-4 |  |
intermediate | 98% |
| 2-溴苯基-β-D-吡喃葡萄糖苷，β-D-Glucopyranoside, 2-bromophenyl | 86832-21-5 |  |
intermediate | 98% |
| Name | CasNo | Structure | Remarks | Scale |
| 4-(2-Chloroethoxy)benzyl chloride 4-(2-氯乙氧基)氯化苄 | 99847-87-7 |  |
intermediate | 白色粉末，99% |
|
 |
|||
|
 |
|||
